SG38183G - Antitumour agent - Google Patents

Antitumour agent

Info

Publication number
SG38183G
SG38183G SG381/83A SG38183A SG38183G SG 38183 G SG38183 G SG 38183G SG 381/83 A SG381/83 A SG 381/83A SG 38183 A SG38183 A SG 38183A SG 38183 G SG38183 G SG 38183G
Authority
SG
Singapore
Prior art keywords
antitumour agent
antitumour
agent
Prior art date
Application number
SG381/83A
Other languages
English (en)
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of SG38183G publication Critical patent/SG38183G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG381/83A 1979-02-27 1983-06-30 Antitumour agent SG38183G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (1)

Publication Number Publication Date
SG38183G true SG38183G (en) 1984-07-20

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
SG381/83A SG38183G (en) 1979-02-27 1983-06-30 Antitumour agent

Country Status (12)

Country Link
US (1) US4347240A (nl)
JP (1) JPS55113718A (nl)
BR (1) BR8001129A (nl)
CA (1) CA1124176A (nl)
CH (1) CH653556A5 (nl)
DE (1) DE3007412A1 (nl)
FR (1) FR2450108B1 (nl)
HK (1) HK23784A (nl)
IT (1) IT1129802B (nl)
MY (1) MY8500010A (nl)
NL (1) NL189999C (nl)
SG (1) SG38183G (nl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
EP0974666A4 (en) 1996-06-26 2004-12-15 Yakult Honsha Kk METHODS FOR TRANSFERRING GENES INTO A CHROMOSOME
DE69842112D1 (de) * 1997-02-11 2011-03-10 Entpr Ie Trd As Bioresearch Ie Nd daraus hergestellte antimikrobielle mittel
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
AU749001B2 (en) * 1997-04-18 2002-06-13 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
WO2005000222A2 (en) * 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
CA2597229A1 (en) * 2005-02-11 2006-08-17 Technologie Biolactis Inc. Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic
US8404823B2 (en) * 2006-10-27 2013-03-26 Kabushiki Kaisha Yakult Honsha Cytokine production regulator gene and use thereof
CN101626773B (zh) * 2006-11-02 2013-04-17 奥力有限公司 一种生体治愈促进剂
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
PL2823822T3 (pl) 2009-11-11 2017-09-29 Alimentary Health Limited Szczep Bifidobakterium
AU2010317422A1 (en) 2009-11-11 2012-05-31 Alimentary Health Limited Probiotic Bifidobacterium strain
EP3589726A1 (en) 2017-02-28 2020-01-08 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
US11813297B2 (en) 2017-03-23 2023-11-14 Katholieke Universiteit Leuven, Ku Leuven R & D Probiotic Lactobacillus casei strain and its uses
US20230106819A1 (en) 2020-03-13 2023-04-06 Precisionbiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
BR8001129A (pt) 1980-11-04
JPS55113718A (en) 1980-09-02
NL189999C (nl) 1993-10-01
DE3007412A1 (de) 1980-11-06
FR2450108B1 (fr) 1988-10-28
JPS6234727B2 (nl) 1987-07-28
IT8067302A0 (it) 1980-02-27
CA1124176A (en) 1982-05-25
CH653556A5 (de) 1986-01-15
NL8001045A (nl) 1980-08-29
MY8500010A (en) 1985-12-31
FR2450108A1 (fr) 1980-09-26
HK23784A (en) 1984-03-23
US4347240A (en) 1982-08-31
IT1129802B (it) 1986-06-11
NL189999B (nl) 1993-05-03

Similar Documents

Publication Publication Date Title
SG38183G (en) Antitumour agent
CS216180A2 (en) Zpusob vyroby oplatek
GB2040591B (en) Rc-networks
GB2045410B (en) Float-drier
GB2046928B (en) Photodrafting
ZA801422B (en) 9-aminoalkylfluorenes
JPS55102412A (en) Selffemulsifying antifrothing agent
JPS5651423A (en) Antiviral agent
JPS5695058A (en) Microosyringe
JPS55102410A (en) Antifrothing agent
GB2065962B (en) Thyratrosns
JPS5690262A (en) Electriccsignal weightinggnetwork
JPS5620636A (en) Held
CS149380A2 (en) Zpusob cisteni merkaptobenzothiazolu
GB2058759B (en) 1-halogen-e-homoeburnanes
JPS564700A (en) Claning agent
HK53786A (en) 17-cycloalkylmethyl-6-methylene-morphinane-derivatives
JPS5621872A (en) Dottmatrixxprinter
JPS5629516A (en) Antiieumycetes agent
GB2060461B (en) Belt-knife splitting-machine
JPS5642976A (en) Groundinggresistance reducing agent
GB8303500D0 (en) Formylpiperidinobutyrophenones
JPS5641681A (en) Groundinggresistance reducing agent
CS175679A2 (en) Vodovaha
BG30041A1 (en) Antitumour means